Parkman Healthcare Partners’s Waters Corp WAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3M Buy
30,206
+3,759
+14% +$1.28M 1.16% 34
2026
Q1
$7.88M Sell
26,447
-15,452
-37% -$5.29M 0.81% 45
2025
Q4
$15.9M Buy
+41,899
New +$15.4M 1.52% 21
2023
Q3
Sell
-40,688
Closed -$10.8M 112
2023
Q2
$10.8M Buy
40,688
+28,821
+243% +$8.02M 1.88% 17
2023
Q1
$3.67M Buy
11,867
+3,063
+35% +$991K 0.8% 44
2022
Q4
$3.02M Sell
8,804
-18,826
-68% -$5.96M 0.8% 46
2022
Q3
$7.45M Buy
27,630
+1,380
+5% +$440K 2.12% 16
2022
Q2
$8.69M Buy
+26,250
New +$8.33M 3.2% 6

Other funds holding WAT

Parkman Healthcare Partners's WAT Position: Q2 2026 in Review

Parkman Healthcare Partners increased its Waters Corp (WAT) stake by 14% in Q2 2026, buying an estimated $1.28M and bringing the position to 30,206 shares worth $11.3M. The position accounts for 1.16% of the portfolio, ranked #34.

Parkman Healthcare Partners first reported a position in WAT in Q2 2022 and has held it in 8 quarters since. The position peaked at $15.9M in Q4 2025. 1,177 funds tracked by Wall St. Rank hold WAT as of Q2 2026.

  • Parkman Healthcare Partners held 30,206 shares of Waters Corp worth $11.3M as of Q2 2026.
  • Parkman Healthcare Partners bought 3,759 Waters Corp shares in Q2 2026, an estimated $1.28M.
  • Waters Corp made up 1.16% of Parkman Healthcare Partners's portfolio in Q2 2026, its #34 holding.
  • Parkman Healthcare Partners first reported a position in Waters Corp in Q2 2022 and has held it in 8 quarters since.
  • Parkman Healthcare Partners's Waters Corp position peaked at $15.9M in Q4 2025.
  • 1,177 funds tracked by Wall St. Rank held Waters Corp as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.